Company news
Design Therapeutics, Inc. news in 2023
Design Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
November 12, 2023
Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
August 13, 2023
Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
August 13, 2023
Design Therapeutics to Present at the 2023 Jefferies Healthcare Conference
May 30, 2023
Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results
May 8, 2023
Design Therapeutics to Present Preclinical Data on its GeneTAC™ Small Molecule, DT-168, for the Treatment of Fuchs Endothelial Corneal Dystrophy at ARVO 2023
April 23, 2023
Design Therapeutics Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
March 13, 2023
Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
February 7, 2023